PLRX icon

Pliant Therapeutics

88 hedge funds and large institutions have $241M invested in Pliant Therapeutics in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

9% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 23

4.23% less ownership

Funds ownership: 87.55%83.32% (-4.2%)

4% less funds holding

Funds holding: 9288 (-4)

Holders
88
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.93M
Puts
$1.45M
Net Calls
Net Calls Change

Top Buyers

1 +$3.77M
2 +$3.6M
3 +$2.87M
4
GPP
Great Point Partners
Connecticut
+$2.86M
5
Goldman Sachs
Goldman Sachs
New York
+$2.31M

Top Sellers

1 -$13.9M
2 -$6.5M
3 -$2.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.29M
5
Walleye Capital
Walleye Capital
New York
-$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$46.8M
2
$26.8M
3
$24.9M
4
$24.6M
5
$17.1M
6
$11.1M
7
$8.43M
8
$7.1M
9
$6.16M
10
$4.5M
11
$4.3M
12
$4.24M
13
$3.92M
14
$3.88M
15
$3.86M
16
$3.77M
17
$3.48M
18
$3.45M
19
$2.86M
20
$2.85M
21
$2.69M
22
$2.65M
23
$2.55M
24
$2.47M
25
$1.77M